3074-27-9 Usage
Uses
Used in Pharmaceutical Industry:
1H-Indole-5-sulfonamide(9CI) is used as a building block for the synthesis of various drugs and compounds, leveraging its structural and chemical properties to contribute to the development of new pharmaceuticals.
1. As a Precursor for Bioactive Molecules:
1H-Indole-5-sulfonamide(9CI) is utilized as a precursor in the preparation of bioactive molecules, which are essential for the creation of pharmaceutical ingredients with specific therapeutic effects.
2. For the Development of Anti-Cancer Treatments:
In the realm of oncology, 1H-Indole-5-sulfonamide(9CI) is employed as a component in the development of new anti-cancer drugs, potentially contributing to treatments for a range of cancers.
3. For Anti-Inflammatory Drug Development:
1H-Indole-5-sulfonamide(9CI) is also used in the formulation of anti-inflammatory drugs, where its properties can help in managing inflammation and related conditions.
4. In Anti-Microbial Drug Synthesis:
1H-Indole-5-sulfonamide(9CI) plays a role in the synthesis of anti-microbial agents, which are crucial for combating various microbial infections.
5. For Organic Synthesis and Chemical Reactions:
Due to the presence of sulfur atoms, 1H-Indole-5-sulfonamide(9CI) is used in organic synthesis for carrying out synthetic transformations and facilitating chemical reactions, broadening its applications beyond direct pharmaceutical uses.
Check Digit Verification of cas no
The CAS Registry Mumber 3074-27-9 includes 7 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 4 digits, 3,0,7 and 4 respectively; the second part has 2 digits, 2 and 7 respectively.
Calculate Digit Verification of CAS Registry Number 3074-27:
(6*3)+(5*0)+(4*7)+(3*4)+(2*2)+(1*7)=69
69 % 10 = 9
So 3074-27-9 is a valid CAS Registry Number.
3074-27-9Relevant academic research and scientific papers
SUBSTITUTED SULFONAMIDES USEFUL AS ANTIAPOPTOTIC BCL INHIBITORS
-
Page/Page column 144, (2012/12/13)
Disclosed are compounds of Formula (I), or a pharmaceutically acceptable salt thereof, wherein: W and Q and G are defined herein. Also disclosed are methods of using such compounds as inhibitors of Bcl-2 family antiapoptotic proteins for the treatment of cancer; and pharmaceutical compositions comprising such compounds.
